Whitepapers/App Notes/Posters

Interview: Current and future vaccine safety aspects

Posted: 4 March 2021 | | No comments yet

Key requirements to ensure patient safety in the present-day development and production of viral vaccines, and the challenges going forward.

COVID-19 has drawn attention to the patient safety aspects of developing and manufacturing viral vaccines. This interview gives insights into the issues and obstacles faced by pharmaceutical companies, the current regulatory framework, and what Merck is doing to prepare itself and its customers for the inevitable next outbreak requiring the speedy development of a vaccine as well as streamlined and fast, but also safe, manufacture.

READ THE INTERVIEW

Send this to a friend